% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • rxpowered rxpowered Apr 8, 2013 11:43 AM Flag

    80% estimate for SFP success in Phase 3 Trial/ Only need .05 Gram change in Hemoglobin

    Financing in place and proven safety track record considered as excellant for SFP and only needs to reach a 0.5 gram change in hemoglobin to demostrate efficacy in phase 3 nearly completed trial,which is certainly obtainable.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I also would say a joint venture or licensing agreement will be coming but they have the funds to get thru the phase 3 Cruise study and will also be saving money from business operations.This ph3 trial is of the upmost significant trial as it will confirm SFP is safe and effective.Their Calcitriol drug will also be launched after the results in which will be the only generic equivilalence IV delivered vitD on the market generating much additional revenue.Brokers were saying the stock was beaten down from $8 becuse they were running low on financing the trial.Now that issue is behind them and should retain the value as before.

      Sentiment: Strong Buy

    • I agree with the safety record and very likely Ph 3 results. Only issue is funding. The stock issuance will not cover all the costs. Hopefully we will get a joint venture or licensing agreement soon.

      Sentiment: Strong Buy

16.60+0.09(+0.55%)2:52 PMEDT